These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
438 related items for PubMed ID: 10415018
1. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis. Rothe H, Hausmann A, Casteels K, Okamura H, Kurimoto M, Burkart V, Mathieu C, Kolb H. J Immunol; 1999 Aug 01; 163(3):1230-6. PubMed ID: 10415018 [Abstract] [Full Text] [Related]
2. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2. Rothe H, O'Hara RM, Martin S, Kolb H. Diabetologia; 1997 Jun 01; 40(6):641-6. PubMed ID: 9222642 [Abstract] [Full Text] [Related]
4. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insulitis of NOD mice and association with both Th1- and Th2-type infiltrates. Martin S, Hibino T, Faust A, Kleemann R, Kolb H. J Autoimmun; 1996 Oct 01; 9(5):637-43. PubMed ID: 8933279 [Abstract] [Full Text] [Related]
5. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Trembleau S, Penna G, Gregori S, Gately MK, Adorini L. Eur J Immunol; 1997 Sep 01; 27(9):2330-9. PubMed ID: 9341777 [Abstract] [Full Text] [Related]
6. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Rajotte RV, Power RF. J Immunol; 1997 Dec 15; 159(12):6298-303. PubMed ID: 9550435 [Abstract] [Full Text] [Related]
7. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. Fox CJ, Danska JS. J Immunol; 1997 Mar 01; 158(5):2414-24. PubMed ID: 9036992 [Abstract] [Full Text] [Related]
8. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF. J Immunol; 1995 May 01; 154(9):4874-82. PubMed ID: 7722337 [Abstract] [Full Text] [Related]
9. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL. J Immunol; 1997 Nov 15; 159(10):4686-92. PubMed ID: 9366391 [Abstract] [Full Text] [Related]
10. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. Gallichan WS, Balasa B, Davies JD, Sarvetnick N. J Immunol; 1999 Aug 01; 163(3):1696-703. PubMed ID: 10415077 [Abstract] [Full Text] [Related]
11. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. Balasa B, Krahl T, Patstone G, Lee J, Tisch R, McDevitt HO, Sarvetnick N. J Immunol; 1997 Nov 01; 159(9):4620-7. PubMed ID: 9379064 [Abstract] [Full Text] [Related]
12. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes. Moritani M, Yoshimoto K, Ii S, Kondo M, Iwahana H, Yamaoka T, Sano T, Nakano N, Kikutani H, Itakura M. J Clin Invest; 1996 Oct 15; 98(8):1851-9. PubMed ID: 8878437 [Abstract] [Full Text] [Related]
13. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice]. Jiang TJ, Zhou ZG, Su H. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug 15; 31(4):499-504. PubMed ID: 16951506 [Abstract] [Full Text] [Related]
14. A murine interleukin-4-Ig fusion protein regulates the expression of Th1- and Th2-specific cytokines in the pancreas of NOD mice. Walz M, Overbergh L, Mathieu C, Kolb H, Martin S. Horm Metab Res; 2002 Oct 15; 34(10):561-9. PubMed ID: 12439784 [Abstract] [Full Text] [Related]
15. Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice. Rothe H, Hibino T, Itoh Y, Kolb H, Martin S. J Autoimmun; 1997 Jun 15; 10(3):251-6. PubMed ID: 9218751 [Abstract] [Full Text] [Related]
16. Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant. Hartmann B, Bellmann K, Ghiea I, Kleemann R, Kolb H. Diabetologia; 1997 Aug 15; 40(8):902-9. PubMed ID: 9267984 [Abstract] [Full Text] [Related]
17. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Weiss L, Zeira M, Reich S, Har-Noy M, Mechoulam R, Slavin S, Gallily R. Autoimmunity; 2006 Mar 15; 39(2):143-51. PubMed ID: 16698671 [Abstract] [Full Text] [Related]
18. Demonstration of a TH1 cytokine profile in the late phase of NOD insulitis. Pilström B, Björk L, Böhme J. Cytokine; 1995 Nov 15; 7(8):806-14. PubMed ID: 8664448 [Abstract] [Full Text] [Related]
19. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice]. Zhang S, Yan X, Zhou PC, Huang C, Yang L, Li X, Lin J, Zhou ZG. Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):568-72. PubMed ID: 18649776 [Abstract] [Full Text] [Related]
20. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D, Momcilovic M, Popadic D, Harhaji L, Miljkovic D, Metz C, Mangano K, Papaccio G, Al-Abed Y, Nicoletti F. J Cell Physiol; 2008 Jun 26; 215(3):665-75. PubMed ID: 18064633 [Abstract] [Full Text] [Related] Page: [Next] [New Search]